Midodrine Versus Placebo in VasoVagal Syncope
Not Applicable
- Conditions
- Vasovagal syncope.Syncope and collapse
- Registration Number
- IRCT138803061965N1
- Lead Sponsor
- Research department of Rajaie Cardiovascular Medical and Research Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
(1) a frequency of at least one episode of syncope during previous 6-month and (2) a positive head-up tilt test.
Exclusion criteria: (1) other causes of syncope; (2) cardiovascular
and /or systemic disease; or (3) systolic blood pressure >150 mmHg or diastolic blood pressure >95 mmHg; or (4) thyrotoxicosis; or (5) renal failure; or (6) pheochromocytoma.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Syncope recurrence. Timepoint: 6-monthe and one year after treatment. Method of measurement: History.
- Secondary Outcome Measures
Name Time Method Satisfaction score. Timepoint: 6-month and one year after treatment. Method of measurement: History (score 0=no response, score 6=excellent response).;Quality of life. Timepoint: 6-month and one year after treatment. Method of measurement: Endicott quality of life questionnaire.